Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel class of vitamin D derivatives for metabolic bone diseases, psoriasis

Oct. 29, 1998

Antiprogestin with potential as an oral postcoital contraceptive in women

Oct. 29, 1998

AERx Diabetes Management System enters phase II trials

Oct. 29, 1998

Amylin announces results from pramlintide phase III studies

Oct. 29, 1998

Pivotal clinical trial results with i.v. Hectorol support NDA submission

Oct. 28, 1998

Symbollon begins evaluating fibrocystic breast disease therapeutic in the clinic

Oct. 28, 1998

P&U amends NDA for once-monthly contraceptive injection

Oct. 28, 1998

Dainippon's aldose reductase inhibitor in phase II in Japan; European development now planned

Oct. 27, 1998

Muse effective in patients with ED resulting from radical prostatectomy

Oct. 26, 1998

Positive phase II results obtained for Allelix's recombinant hPTH in osteoporosis

Oct. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...